Dr. Joe K. Tung, MBA, MD

Dr. Tung practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Tung's NPI, 1871121509, was assigned on March 29, 2020. Dr. Tung graduated from Harvard Medical School in 2020. Dr. Tung holds Pennsylvania license MD480251.

Dr. Tung's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Tung's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Tung is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Tung to 2 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tung practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Tung's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Tung is licensed in Pennsylvania.

CMS data shows 212 Medicare services from Dr. Tung across 7 procedure codes in 2024, for 101 Medicare patients. Medicare paid $8,207 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Tung in 2024. The largest group is 65 to 74, with 40 patients. 74% of them have high cholesterol, and 65% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tung's median patient age at 68, with 49% women.

In 2024, Dr. Tung wrote 483 Medicare Part D claims for 202 patients. 87% of them were for generic drugs. CMS names the drug for 367 of them, across 11 drugs with 11 or more claims each, at $78,835 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Tung for performance year 2024, reported as part of a group. Dr. Tung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tung as offering telehealth. CMS counts 39 procedures of melanoma (skin cancer) excision by Dr. Tung, more than 84% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Tung, published from 2012 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Dermatology, Lymphangiogenesis and Lymphatic Vessels. Dr. Tung has published most often in J Am Acad Dermatol. Dr. Tung's most frequent co-authors are Alaina J. James, MD, PhD, Lauryn Marlene Falcone, MD, PhD and Amit Prasad, MD.

CMS Open Payments shows 529 general payments to Dr. Tung from 26 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Abbvie Inc. paid the most, $84,005. It also lists 9 research payments totaling $811 in 2024, naming 1 clinical trial.

Dr. Tung graduated from Harvard Medical School in 2020.